# Dammarenediol II **Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/dammarenediol-ii **Data Source:** Hermetica Superfoods Ingredient Encyclopedia **Updated:** 2026-03-30 **Evidence Score:** 2 / 10 **Category:** Compound **Also Known As:** 20S-Dammarenediol II, DDS product, Dammarane-3β,20S-diol, (20S)-Dammar-24-ene-3β,20-diol, Protopanaxadiol precursor ## Overview Dammarenediol II is a tetracyclic triterpenoid alcohol that serves as the central precursor in the biosynthesis of ginsenosides, the primary bioactive compounds in Panax ginseng. It is enzymatically hydroxylated by the cytochrome P450 enzyme CYP716A47 to form protopanaxadiol, initiating the downstream production of pharmaceutically relevant ginsenosides. ## Health Benefits • No direct health benefits established - research limited to biosynthetic pathway studies • Functions as precursor to ginsenosides (evidence quality: preliminary - in vitro only) • Converted to protopanaxadiol by CYP716A47 enzyme in biosynthesis (evidence quality: preliminary - yeast expression systems) • Part of triterpene saponin production pathway (evidence quality: preliminary - plant metabolomic studies) • No human clinical trials or therapeutic applications documented (evidence quality: none) ## Mechanism of Action Dammarenediol II is synthesized from 2,3-oxidosqualene via a two-step cyclization catalyzed by dammarenediol II synthase (DDS), a member of the oxidosqualene cyclase family. The resulting tetracyclic scaffold is then regiospecifically hydroxylated at the C-12 position by the cytochrome P450 monooxygenase CYP716A47, yielding protopanaxadiol. Protopanaxadiol subsequently undergoes further hydroxylation by CYP716A53v2 to form protopanaxatriol, which serves as the aglycone backbone for a broad class of ginsenosides including Rb1, Rg1, and Re. ## Clinical Summary No human clinical trials have investigated dammarenediol II directly, as research has been confined to in vitro biochemical characterization and heterologous expression studies in yeast systems such as Saccharomyces cerevisiae. Studies reconstructing the ginsenoside biosynthetic pathway in engineered yeast have confirmed dammarenediol II's obligate role as a pathway intermediate, but these findings do not translate directly to human pharmacological activity. Its biological relevance in humans is currently inferred entirely from the well-documented clinical literature on downstream ginsenosides, not from any independent efficacy data. The evidence base for dammarenediol II itself must be classified as preliminary and mechanistic only. ## Nutritional Profile Dammarenediol II is a tetracyclic triterpenoid compound (molecular formula C30H52O2, molecular weight 448.73 g/mol) and is not a nutritional ingredient in the conventional sense - it contains no meaningful macronutrients, micronutrients, vitamins, minerals, fiber, or protein. As a pure biosynthetic intermediate compound, it is a steroidal-type alcohol belonging to the dammarane-type triterpene class. It possesses two hydroxyl groups at C-3 and C-20 positions, which are the functional sites for subsequent enzymatic modifications. Concentrations in Panax ginseng root tissue are extremely low (estimated trace quantities in the nanogram-to-microgram per gram dry weight range), as it exists transiently as a metabolic intermediate rather than accumulating as a stable end product. Its bioavailability as an isolated compound is expected to be poor due to its highly lipophilic nature (high logP estimated >7), limiting aqueous solubility to approximately <1 mg/mL. It is synthesized from 2,3-oxidosqualene via the enzyme dammarenediol synthase (DS) and serves exclusively as a committed precursor in the ginsenoside biosynthetic pathway. No caloric value, dietary reference intake, or nutritional significance has been established for this compound. ## Dosage & Preparation No clinically studied dosage ranges exist for Dammarenediol II as it lacks human clinical data. The compound is used only in microgram-to-milligram quantities for in vitro enzymatic research assays. Consult a healthcare provider before starting any new supplement. ## Safety & Drug Interactions No human safety data, toxicology studies, or adverse event reports exist specifically for isolated dammarenediol II, as it is not commercially available as a standalone supplement. Because it is an endogenous biosynthetic intermediate rather than a final bioactive compound, direct human exposure through supplementation is not currently a practical consideration. Any safety assumptions should be derived cautiously from the broader triterpenoid and ginsenoside literature, which identifies potential interactions with anticoagulants, hypoglycemic agents, and immunosuppressants. Pregnant or nursing individuals should avoid speculative supplementation with any ginseng-derived triterpenoids, including precursors, until dedicated safety data are available. ## Scientific Research No human clinical trials, randomized controlled trials (RCTs), or meta-analyses have been conducted on Dammarenediol II. All available research consists of in vitro enzymatic assays, yeast expression systems, and plant metabolomic/transcriptomic studies examining its role in biosynthesis, with no PMIDs referencing human outcome studies. ## Historical & Cultural Context No historical or traditional medicinal uses are documented for isolated Dammarenediol II. While it functions as a biosynthetic intermediate in Panax ginseng (used in Traditional Chinese Medicine for vitality), the compound itself has no traditional therapeutic references. ## Synergistic Combinations Not applicable - research compound only ## Frequently Asked Questions ### What is dammarenediol II and where does it come from? Dammarenediol II is a tetracyclic triterpenoid alcohol biosynthesized in Panax ginseng roots from 2,3-oxidosqualene through a cyclization reaction catalyzed by the enzyme dammarenediol II synthase (DDS). It represents the first committed step in the dammarane-type triterpenoid pathway, branching from the general sterol biosynthesis route. It is not found in significant quantities as a free compound in commercial ginseng extracts. ### Is dammarenediol II the same as a ginsenoside? No, dammarenediol II is not a ginsenoside but rather the aglycone precursor from which ginsenosides are ultimately derived. Ginsenosides such as Rb1, Rg1, and Re are glycosylated derivatives of protopanaxadiol or protopanaxatriol, which are themselves downstream hydroxylation products of dammarenediol II. The addition of sugar moieties by UDP-dependent glycosyltransferases is what defines a compound as a ginsenoside. ### What enzyme converts dammarenediol II to protopanaxadiol? The cytochrome P450 monooxygenase CYP716A47, expressed predominantly in Panax ginseng root tissue, catalyzes the hydroxylation of dammarenediol II at the C-12 position to produce protopanaxadiol. This reaction requires NADPH and molecular oxygen as cofactors. CYP716A47 was functionally characterized through heterologous expression in Saccharomyces cerevisiae, confirming its specific substrate preference for dammarenediol II. ### Does dammarenediol II have any proven health benefits in humans? There are currently no proven health benefits of dammarenediol II in humans, as no clinical trials or human pharmacokinetic studies have been conducted on this compound in isolation. Its pharmacological significance is entirely indirect, deriving from its role as an obligate precursor to bioactive ginsenosides that have been studied in human trials. Attributing ginseng's clinical effects to dammarenediol II specifically would not be scientifically supported by existing evidence. ### Why is dammarenediol II important in supplement research? Dammarenediol II is important in supplement and pharmaceutical research primarily because engineering its biosynthetic pathway in microbial hosts like yeast offers a scalable, plant-independent route to produce rare ginsenosides such as compound K or Rh2. Reconstructing the full pathway from dammarenediol II synthase through downstream CYP450s and glycosyltransferases in Saccharomyces cerevisiae has been demonstrated in published metabolic engineering studies. This biotechnological relevance makes it a target for synthetic biology rather than direct therapeutic use. ### What is the difference between dammarenediol II and the ginsenosides it produces? Dammarenediol II is a precursor triterpene that lacks the sugar moieties attached by subsequent enzymatic steps, whereas ginsenosides are the final glycosylated compounds with documented biological activity. While dammarenediol II itself shows no direct health effects in human studies, it serves as the essential starting material in the metabolic pathway that generates bioactive ginsenosides like Rb1 and Rg1. The conversion from the aglycone (dammarenediol II) to sugar-containing ginsenosides significantly alters the compound's biological properties and absorption characteristics. ### Can dammarenediol II be absorbed directly from supplements, or must it be converted to ginsenosides first? Current evidence suggests dammarenediol II has minimal direct bioavailability and must be enzymatically converted to ginsenosides to exert biological effects; however, human absorption studies specifically measuring dammarenediol II are lacking. The compound is primarily of research interest as a biosynthetic intermediate rather than as a standalone supplement ingredient. Most commercial supplements contain standardized ginsenosides rather than isolated dammarenediol II due to the latter's lack of established efficacy. ### How do scientists use dammarenediol II in laboratory research on ginsenoside production? Researchers use dammarenediol II as a substrate in cell-free and yeast expression systems to study the CYP716A47 enzyme and optimize the biotechnological production of ginsenosides, rather than for direct health applications. These in vitro studies help identify enzymatic bottlenecks in the ginsenoside synthesis pathway and inform strategies for increasing bioactive compound yields in cultivated ginseng. Current research remains at the preliminary stage, with findings derived from controlled laboratory settings rather than whole-plant or human models. --- *Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com* *License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*